tiprankstipranks
Akebia Therapeutics (AKBA)
NASDAQ:AKBA
US Market

Akebia Therapeutics (AKBA) Income Statement

Compare
1,380 Followers

Akebia Therapeutics Income Statement

Last quarter (Q3 2024), Akebia Therapeutics's total revenue was $37.43M, a decrease of -10.98% from the same quarter last year. In Q3, Akebia Therapeutics's net income was $-20.04M. See Akebia Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 194.62M$ 292.60M$ 213.58M$ 295.31M$ 335.00M
Gross Profit
$ 120.47M$ 207.81M$ 60.18M$ -601.00K$ 189.66M
Operating Expenses
$ 166.73M$ 270.99M$ 325.50M$ 375.84M$ 475.95M
Depreciation and Amortization
$ 37.63M$ 35.28M$ 36.13M$ 33.59M$ 36.42M
EBITDA
$ -6.87M$ -43.26M$ -225.96M$ -341.00M$ -247.64M
Operating Income
$ -46.26M$ -63.18M$ -265.32M$ -376.44M$ -286.29M
Other Income/Expenses
$ -5.67M$ -13.45M$ -17.52M$ -5.63M$ -2.00K
Pretax Income
$ -51.92M$ -92.56M$ -282.84M$ -383.46M$ -286.29M
Net Income
$ -51.92M$ -106.01M$ -244.87M$ -349.87M$ -279.66M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.28$ -0.58$ -1.48$ -2.53$ -2.36
Diluted EPS
$ -0.28$ -0.58$ -1.48$ -2.53$ -2.36
Weighted Average Shares Outstanding
187.47M 182.78M 165.95M 138.46M 118.40M
Weighted Average Shares Outstanding (Diluted)
187.47M 182.78M 165.95M 138.46M 118.40M
Currency in USD

Akebia Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis